| | | By Tara Bannow and Bob Herman Thumy Phan for STAT Welsh Carson paints itself as nobler than other private equity firms. A STAT special report reveals a relentless pursuit of profits. Read More | By Tara Bannow Adobe A slightly higher share of advanced practice clinicians take funding from drug and device makers relative to doctors, a new JAMA study finds. Read More | By Usha Lee McFarling Michael Reynolds/Pool via AP "We have the chance to do more than diagnostics, and actually figure out how to cure people," says former NIH director Francis Collins. Read More | Sponsored Insight by STAT Events The 2022 STAT Summit In a few short weeks, on November 15 and 16, join us for silo-breaking and solution-focused conversations with speakers like Ken Frazier, Tony Fauci, Kathrin Jansen, and more! They'll discuss the future of companies like Pfizer and Vertex, deliver insights on CRISPR, and ask how we'll survive the journey to Mars. Learn more. | By Daryl Pritchard and Susanne Munksted Adobe The promise of personalized medicine isn't being fully met because of challenges implementing it in clinical practice. Read More | |
No comments